SEC Form 5 · accession 0001127602-15-002138
ALLERGAN INC · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David E I Pyott
Officer — Chairman of the Board and CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 20, 2015 · 1:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850693
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $125.07 | Mar 20, 2014 | G | 257,756 | A | — | Feb 21, 2024 | Common Stock | 257,756 | 257,756 | I |
| Employee Stock Option (Right to Buy)F2 | $125.07 | Mar 20, 2014 | G | 257,756 | D | — | Feb 21, 2024 | Common Stock | 257,756 | 0 | D |
Explanation of responses
- F1The option becomes exercisable in four equal annual installments beginning February 21, 2015.
- F2The option becomes exercisable in four equal annual installments beginnng February 21, 2015.